Researchers are looking for adults aged 60 and older with a history of urinary tract infection (UTI) in the past 2 years. The study will investigate the efficacy of an investigational vaccine compared to placebo in the prevention of E. coli disease.

This clinical research study is aimed at characterizing the safety of the FreeStyle Libre Glucose Monitoring System (a continuous glucose monitoring (CGM) system) in children and young adults (ages 4 to 30).

Researchers are conducting a clinical trial to evaluate the efficacy and safety of an investigational vaccine called mRNA-1647 against CMV infection in healthy female adults ages 16 to 40.

Researchers are looking for adults with Hidradenitis Suppurativa (HS) to participate in a clinical research study. This study is aimed at evaluating investigational medication for HS over 62 weeks.

Researchers are looking for adolescents and adults with moderate-to-severe Atopic Dermatitis previously treated with dupilumab (DUPIXENT). The study will investigate the safety and effectiveness of the study drug to reduce the area and severity of eczema symptoms.

Researchers are looking for adolescents and adults who identify as a race other than White with moderate-to-severe Atopic Dermatitis and a history of inadequate response to treatment with topical medications. The study will investigate the safety and effectiveness of the study drug to reduce the area and severity of eczema symptoms.

Researchers are exploring whether adding dupilumab to oral immunotherapy (OIT) will enhance the safety and efficacy of OIT in patients with a milk allergy.

This is a Phase 3, open-label study to evaluate the long-term safety of difamilast ointment 1% in subjects ≥2 years of age with mild to moderate AD. The study will also evaluate the long-term efficacy of difamilast ointment 1%, including durability of response.

NATiV3 is a clinical trial for adults 18 years of age and older with NASH and liver fibrosis stage 2 or 3. The purpose of the trial is to evaluate if an oral investigational drug, called lanifibranor, is a safe and effective potential treatment option for NASH.

NYU Langone Health and Boston University School of Medicine are conducting a virtual study to understand how older adults' interactions with their partners impact their wellbeing when they experience memory changes.

Cardiac Insight Inc., a medical device company developing advanced, body worn ECG sensing technology, is looking for adult and pediatric volunteers to help evaluate the usability of their newest self-worn ECG sensor.

Researchers are looking for adult participants with a minimum 1-year history of migraine attacks, with an average of 4 to 14 migraine days per month, to participate in a clinical research study evaluating the efficacy of an FDA-approved drug for the prevention of migraine attacks.

The RECIPE study is a 5-year study assessing the safety and effectiveness of an FDA approved implantable device called "eCoin ITNS" to treat urgency urinary incontinence.

Researchers are conducting a study to evaluate the safety and effectiveness of an investigational drug, compared to a PPI control medication like Prilosec, in healing Erosive Esophagitis (EE).